:I/II randomised

Vanita Noronha1, Vijay Patil2, Nandini Menon1

  • 1Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India.

概括

将静脉注射的潘托普拉添加到缓性化疗中,并没有改善头部和部状细胞癌患者的无进展生存率. 该研究发现,接受潘托普拉的患者在生存率或反应率方面没有显著的益处.